Connection

Anand Sharma to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications Anand Sharma has written about Erlotinib Hydrochloride.
Anand Sharma
Connection Strength
0.027
Erlotinib Hydrochloride
  1. Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. J Clin Oncol. 2013 Apr 10; 31(11):1415-21.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.